• Oct 08, 2015 | Webcast

    Treatment of Disorders: Bone-Kidney Crosstalk

    Paul Miller, M.D., FACP; Mary Leonard, M.D.; Tamara Isakova, M.D.; Stuart Sprague, D.O.; Seiji Fukumoto, M.D., Ph.D.
    Investigation of Metabolic Bone Diseases, Integrative Physiology of the Skeleton

    Paul Miller, M.D., FACP, Colorado Center for Bone Research
    Mary Leonard, M.D., Stanford School of Medicine

    Phosphate Binding in the Control of FGF23
    Tamara Isakova, M.D., Northwestern University

    Renal Osteodystrophy/Treatment
    Stuart Sprague, D.O., Northshore University Health System

    Treatment of FGF23-related Hypophosphatemic Diseases
    Seiji Fukumoto, M.D., Ph.D., University of Tokyo Hospital

    Supported by an educational grant from Fresenius Medical Care North America, Keryx Biopharmaceuticals, Inc., Lilly, Merck & Co., Inc., Ultragenyx Pharmaceutical Inc.

    Length: 60 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details